Fiserv (FISV) Q4 2008 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2008 earnings summary
5 Nov, 2026Executive summary
2008 revenue rose 22% to $4.739B and operating income rose 20% to $890M, driven mainly by the CheckFree acquisition; continuing-operations income and diluted EPS declined.
Disposals of Health, most ISS, and a 51% Insurance interest reshaped the portfolio; proceeds supported debt reduction, while Health and ISS sale gains lifted discontinued-operations income.
Financial highlights
FY revenue was $4.739B, up 22% YoY; processing and services revenue rose to $3.616B from $2.668B, while product revenue fell to $1.123B from $1.229B.
Operating income increased to $890M from $739M; operating margin eased to 18.8% from 19.0%.
Continuing-operations income was $346M vs. $414M; net income was $569M vs. $439M and diluted EPS was $3.49 vs. $2.60, including discontinued-operations gains.
Q4 revenue was $1.061B, operating income $219M, continuing-operations income $71M, net income $62M, and diluted EPS $0.39.
Outlook and guidance
2009 continuing-operations tax rate expected at 38.5%, compared with 45.1% in 2008; 2008 included a 6.9-point effect from the Insurance sale tax provision.
2009 outlook anticipated fewer account-processing switches among depository institutions and ongoing demand for deposit-gathering, efficiency, risk, and regulatory products.
CheckFree integration targets included annual cost savings above $100M and annual revenue synergies above $125M over several years; realization and timing remained uncertain.
Latest events from Fiserv
- A $1B efficiency plan backs a push to renew Clover, enterprise, and banking growth.FISV
Citi’s 15th Annual FinTech Conference - FY1999 delivered 14.1% revenue growth as acquisitions and financial-tech demand expanded the business.FISV
Q4 1999 - Outsourcing, software investment and acquisitions underpin growth amid rising processing needs.FISV
Q4 2000 - Revenue grew 14%, led by financial institution services, as securities markets softened.FISV
Q4 2001 - FY02 growth and cash generation advanced, despite securities-market weakness and heavy acquisition spending.FISV
Q4 2002 - Acquisitions drove FY03 growth as net income rose to $315.0M and organic growth remained modest.FISV
Q4 2003 - FY growth accelerated, led by Health, as a securities-clearing sale reshaped the portfolio.FISV
Q4 2004 - Revenue grew 9%, while highlighted adjusted EPS was $2.30 after one-time items.FISV
Q4 2005 - Revenue grew 12%, while operating income held flat and insurance led growth.FISV
Q4 2006